Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aisen

Showing results (41-50 of 981) with videos related to

Pageof 99
Sort By:
Journal of Rehabilitation Research and Development|April 3, 2002
Judging the judges: keeping objectivity in peer reviewMindy L Aisen
The Journal of Nutrition, Health & Aging|March 21, 2009
Interpreting biomarker data in therapeutic trialsP S Aisen
Radiology|September 1, 1990
Body MR imaging and the local staging of neoplasmsA M Aisen
Neurology|January 17, 2018
Author response: A phase 3 trial of IV immunoglobulin for Alzheimer diseasePaul S Aisen
The Lancet. Neurology|July 10, 2003
The potential of anti-inflammatory drugs for the treatment of Alzheimer's diseasePaul S Aisen
Radiology|March 26, 2011
Science to practice: can the diagnosis of fibrosis with magnetization contrast MR aid in the evaluation of patients with Crohn disease?Alex M Aisen
The Journal of Prevention of Alzheimer'S Disease|January 19, 2016
Cognitive/Clinical Endpoints for Pre-Dementia AD TrialsP S Aisen
The American Journal of Nursing|December 1, 1970
Up the vocational stairsM W Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Development of a disease-modifying treatment for Alzheimer's disease: AlzhemedPaul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Challenges to demonstrating disease-modifying effects in Alzheimer's disease clinical trials"Paul S Aisen
Pageof 99

Showing results (41-50 of 981) with videos related to

Sort By:
Pageof 99
Journal of Rehabilitation Research and Development|April 3, 2002
Judging the judges: keeping objectivity in peer reviewMindy L Aisen
The Journal of Nutrition, Health & Aging|March 21, 2009
Interpreting biomarker data in therapeutic trialsP S Aisen
Radiology|September 1, 1990
Body MR imaging and the local staging of neoplasmsA M Aisen
Neurology|January 17, 2018
Author response: A phase 3 trial of IV immunoglobulin for Alzheimer diseasePaul S Aisen
The Lancet. Neurology|July 10, 2003
The potential of anti-inflammatory drugs for the treatment of Alzheimer's diseasePaul S Aisen
Radiology|March 26, 2011
Science to practice: can the diagnosis of fibrosis with magnetization contrast MR aid in the evaluation of patients with Crohn disease?Alex M Aisen
The Journal of Prevention of Alzheimer'S Disease|January 19, 2016
Cognitive/Clinical Endpoints for Pre-Dementia AD TrialsP S Aisen
The American Journal of Nursing|December 1, 1970
Up the vocational stairsM W Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Development of a disease-modifying treatment for Alzheimer's disease: AlzhemedPaul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Challenges to demonstrating disease-modifying effects in Alzheimer's disease clinical trials"Paul S Aisen
Pageof 99